Development of a stability-indicating HPLC method of Etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR

被引:18
|
作者
Djabrouhou, Nadia [1 ]
Guermouche, Moulay-Hassane [1 ]
机构
[1] USTHB, Lab Chromatog, Fac Chim, Bab Ezzouar 16133, Alger, Algeria
关键词
HPLC; Etifoxine; Stress degradation; LC-MS/TOF; H-1 and C-13 NMR; Validation; STRESS DEGRADATION; FORCED DEGRADATION; ANXIOLYTIC ETIFOXINE; RECEPTOR SUBTYPES; MICE; BEHAVIOR; DRUG; SULFATE; ANXIETY; ASSAY;
D O I
10.1016/j.jpba.2014.07.017
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This paper describes a new LC-MS/TOF method for the degradation products determination when Etifoxine (ETI) is submitted to different stress conditions. Chromatography is performed by using Kromasil C18 column (250 mm x 4.6 mm, 5 mu m particle size). The selected mobile phase consists of formate buffer 0.02 M, pH 3 and methanol (70/30, v/v). ETI is submitted to oxidative, acidic, basic, hydrolytic, thermal and UV light degradations. Detection is made at 254 nm by photodiode array detector and mass spectrometry. A number of degradation products (DPs) called DPA, DPB, DPC and DPD are found depending on the stress; DPA with heat, DPA and DPB in acidic media or under UV-light; DPA, DPB and DPC under basic stress; DPA, DPB, DPC and DPD with oxidation. LC-MS/TOF is used to characterize the four DPs of ETI resulting from different stress conditions. H-1 and C-13 NMR are used to confirm the DP structures. The ETI fragmentation pathway is proposed. The method is validated with reference to International Conference on Harmonization guidelines and ETI are selectively determined in presence of its DPs, demonstrating its stability-indicating nature. Finally, for the validation step, specificity, linearity, accuracy and precision are determined for ETI and its DPs. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 50 条
  • [11] Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS
    Cholleti, Vijaykumar
    Kumar, Yalavarti Ravindra
    Pasula, Aparna
    Surya, Prakash Rao Pydimarry
    BIOMEDICAL CHROMATOGRAPHY, 2022, 36 (09)
  • [12] Study of Forced Degradation Behavior of Amisulpride by LC-MS and NMR and Development of a Stability-Indicating Method
    Sweidan, Kamal
    Elayan, Mohammad
    Sabbah, Dima
    Idrees, Gada
    Arafat, Tawfiq
    CURRENT PHARMACEUTICAL ANALYSIS, 2018, 14 (02) : 157 - 165
  • [13] Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS
    Wu, Chunyong
    Xu, Xue
    Feng, Chao
    Shi, Yuanyuan
    Liu, Wenyuan
    Zhu, Xiaoyun
    Zhang, Junying
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 98 : 356 - 363
  • [14] Development and validation of a RP-HPLC method for stability-indicating assay of gemifloxacin mesylate including identification of related substances by LC-ESI-MS/MS, 1H and 13C NMR spectroscopy
    Rao, R. Nageswara
    Naidu, Ch. Gangu
    Prasad, K. Guru
    Narasimha, R.
    BIOMEDICAL CHROMATOGRAPHY, 2011, 25 (11) : 1222 - 1229
  • [15] Development and validation of a stability-indicating assay including the isolation and characterization of degradation products of metaxalone by LC-MS
    Rao, R. Nageswara
    Farah, Hassan
    Sahu, Prafulla Kumar
    Janarthan, Muthumani
    Naidu, Ch. Gangu
    BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (12) : 1733 - 1740
  • [16] Stability-Indicating Related Substances HPLC Method for Droxidopa and Characterization of Related Substances Using LC-MS and NMR
    Kumar, Thangarathinam
    Ramya, Mohandass
    Xavier, S. J. Arockiasamy
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2016, 54 (10) : 1761 - 1770
  • [17] Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, 1H and 13C NMR spectroscopic characterization of degradation products and process related impurities
    Rao, R. Nageswara
    Naidu, Ch Gangu
    Prasad, K. Guru
    Santhakumar, B.
    Saida, Shaik
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 78-79 : 92 - 99
  • [18] Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR
    Liu, Lei
    Cao, Na
    Ma, Xingling
    Xiong, Kaihe
    Sun, Lili
    Zou, Qiaogen
    Yao, Lili
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 117 : 325 - 332
  • [19] Stability-Indicating Method and LC-MS-MS Characterization of Forced Degradation Products of Sofosbuvir
    Nebsen, M.
    Elzanfaly, Eman S.
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2016, 54 (09) : 1631 - 1640
  • [20] HPLC AND LC-MS STUDIES ON STRESS DEGRADATION BEHAVIOR OF LEVOCETIRIZINE AND DEVELOPMENT OF A VALIDATED SPECIFIC STABILITY-INDICATING METHOD
    Gunjal, Rahul P.
    Raju, G.
    Babu, A. Ramesh
    Mallikarjun, N.
    Shastri, Nalini
    Srinivas, R.
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2011, 34 (12) : 955 - 965